Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Vujkovic-Cvijin I"'
Autor:
Ortiz AM; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Flynn JK; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., DiNapoli SR; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Vujkovic-Cvijin I; Mucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD, USA., Starke CE; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Lai SH; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Long ME; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Sortino O; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Vinton CL; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Mudd JC; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Johnston L; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA., Busman-Sahay K; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA.; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, USA., Belkaid Y; Mucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD, USA.; NIAID Microbiome Program, NIH, Bethesda, MD, USA., Estes JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA.; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, USA.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, USA., Brenchley JM; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA. jbrenchl@niaid.nih.gov.
Publikováno v:
Nature medicine [Nat Med] 2018 Sep; Vol. 24 (9), pp. 1313-1316. Date of Electronic Publication: 2018 Jul 30.
Autor:
Ortiz AM; Program in Tissue Immunity and Repair and Immunopathogenesis Section, Lab of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, USA., Klase ZA; Program in Tissue Immunity and Repair and Immunopathogenesis Section, Lab of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, USA.; Department of Biological Sciences, University of the Sciences, Philadelphia, Pennsylvania, USA., DiNapoli SR; Program in Tissue Immunity and Repair and Immunopathogenesis Section, Lab of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, USA., Vujkovic-Cvijin I; Division of Experimental Medicine, Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA., Carmack K; Program in Tissue Immunity and Repair and Immunopathogenesis Section, Lab of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, USA., Perkins MR; Program in Tissue Immunity and Repair and Immunopathogenesis Section, Lab of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, USA., Calantone N; Program in Tissue Immunity and Repair and Immunopathogenesis Section, Lab of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, USA., Vinton CL; Program in Tissue Immunity and Repair and Immunopathogenesis Section, Lab of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, USA., Riddick NE; Program in Tissue Immunity and Repair and Immunopathogenesis Section, Lab of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, USA., Gallagher J; Program in Tissue Immunity and Repair and Immunopathogenesis Section, Lab of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, USA., Klatt NR; Program in Tissue Immunity and Repair and Immunopathogenesis Section, Lab of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, USA.; Department of Pharmaceutics, Washington National Primate Research Center, University of Washington, Seattle, Washington, USA., McCune JM; Division of Experimental Medicine, Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA., Estes JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA., Paiardini M; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Brenchley JM; Program in Tissue Immunity and Repair and Immunopathogenesis Section, Lab of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, USA.
Publikováno v:
Mucosal immunology [Mucosal Immunol] 2016 Mar; Vol. 9 (2), pp. 458-67. Date of Electronic Publication: 2015 Aug 19.